Antithrombotic therapy for lower extremity artery disease: is more intense therapy required?

Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):94-96. doi: 10.1093/ehjcvp/pvz044.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aorta
  • Arteries
  • Cardiology*
  • Fibrinolytic Agents
  • Humans
  • Lower Extremity
  • Peripheral Vascular Diseases*

Substances

  • Fibrinolytic Agents